Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
3
×
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
drugs
eli lilly
fda
genentech
gilead sciences
indiana blog main
indiana top stories
intercept pharmaceuticals
johnson & johnson
national
nonalcoholic steatohepatitis
obeticholic acid
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
xencor
4d molecular therapeutics
What
known
3
×
approved
bio
disease
drug
fatty
liver
nash
new
roundup
biopharma
companies
congress
congressional
crispr
data
digital
epidemic
executives
fda
feud
frenzied
group
growing
horizon
intercept
isn’t
later
led
marketed
medicine
merck
month
news
nonalcoholic
ny
pharma
race
roster
spectacles
Language
Current search:
" san francisco top stories "
×
known
×
" clinical trials "
×
" new york top stories "
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More